Archer Materials Limited announced that the company has appointed Dr. Rebecca Soffe to the position of Manager, Biotechnology. Dr. Soffe's appointment to this newly created role is part of Archer's strategy to commercially develop materials technology in the Company's key vertical of Human Health. Dr. Soffe commenced the role 9 September 2020, is full-time, and based in Archer's Sydney CBD Office reporting directly to Archer's CEO. The immediate priority of the Appointment is to technically develop the intellectual property claims in Archer's 100% owned international patent application relevant to the Company's graphene-based biosensor technology. Dr. Soffe's experience is in the design, fabrication, and integration of `lab on a chip' biosensor devices.